Intermittent Low Energy Diet in CKD: MIX UP Feasibility Study
Launched by KING'S COLLEGE HOSPITAL NHS TRUST · Nov 7, 2018
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • aged 18-75 years
- • KDIGO defined CKD (all categories)
- • BMI ≥30kg/m2
- • able to provide written informed consent in English
- Exclusion Criteria:
- • pregnant or breastfeeding women
- • conservatively managed CKD stage 5
- • palliative or active treatment for cancer
- • unstable chronic liver disease
- • type 1 diabetes and type 2 diabetes controlled with anti-hyperglycaemic medication
- • previous bariatric surgery
- • unable to provide written informed consent
- • significant psychiatric disorder or uncontrolled depression
- • participated in a weight management drug trial in the previous 3 months
- • uncontrolled epilepsy
- • alcohol or substance abuse
About King's College Hospital Nhs Trust
King's College Hospital NHS Trust is a leading healthcare institution in the United Kingdom, renowned for its commitment to providing high-quality patient care and advancing medical research. With a strong emphasis on clinical excellence, the Trust supports a wide range of clinical trials across various specialties, leveraging its state-of-the-art facilities and a multidisciplinary team of healthcare professionals. By fostering innovation and collaboration, King's College Hospital NHS Trust aims to enhance treatment options and improve outcomes for patients, while contributing to the global body of medical knowledge through rigorous scientific investigation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Helen L MacLaughlin, PhD
Principal Investigator
King's College Hospital NHS Fundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials